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Standardizationof Serum CholesterolAssaysby Use of Serum Calibrators
and DirectAdditionof Liebermann-BurchardReagent
Martijn B. Katan, Frits van der Haar,’ Daan Kromhout,2 and Frans J. M. Schouten
Serum cholesterolconcentrationsof subjectsinepide-
miological studies were measured after direct addition of
Liebermann-Burchard reagent; results were calibrated with
human serum pools assayed according to Abell et al. (J.
Biol. Chem. 195: 357-366, 1952). Accuracy and precision
were monitored for six years by analysis of internal-control
pools and blind external-control pools. For various inter-
nal-controlpools,the imprecision(CV) of the long-term
averages of run means ranged from 0.5 to 0.9%. The
within-run CV for internal control and patients’ sera was
about 1 %. For blind control sera with different concen-
trations (provided by the Centers for Disease Control, At-
lanta, GA, over the same period), the average difference
per three-month period between the values found and the
target values was usually between -0.5% and +0.7%
for medium-concentration pools and between -2% and
+2% for low- and high-concentration pools (extreme
values: -2.4% and +2.5%). The CV per three-month
period ranged from 0.6 to 2.7%. Sera from subjects on
diets of high or low linoleic acid content were analyzed to
study the effect of the fatty acid portion of serum choles-
terol esters; the differences between values obtained with
the comparison method and the direct method was insig-
nificanton bothdiets.We concludethatthe useof serum
calibrators eliminates the bias inherent in the direct
method.
AddftlonalKeyphrases: calibrators prepared from frozen serum
#{149}effect of dietary fatty acids on serum cholesterol values
The Liebermann-Burchard reagent, in some modificatmon
or other (e.g., 1), is widely used for determination of choles-
terol in serum (2). However, its color yield per molecule differs
for cholesterol in serum and for pure cholesterol in calibration
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solutions, presumably because most of the cholesterol in
serum is present as esters of long-chain fatty acids and not as
free cholesterol (3), or becausethe Liebermann-Burchard
reagent interacts differently with the background matrix of
serum and withthesolventof calibration solutions (2). With
the reference method of Abell et al. (4), one circumvents these
problems by extracting the cholesterol from serum and sa-
ponifying it,therebybringingit into the same physical state
as the material used for calibration; the color developed is
thereforeread against that of an identical background.
However, this method is laborious and cannot easily be au-
tomated.The Lipid Research Clinics AutoAnalyzer methods
involve extraction with isopropanol (5), and a serum calibrator
is used tocorrect forremaining bias, e.g., from thepresence
ofesterifiedcholesterol intheserum extract(3).
We have found that highly accurateand precise values for
serum cholesterol can be obtained without extraction, by
adding Liebermann-Burchard reagent directly to serum and
using sera of known cholesterol concentration instead of
cholesterol solutions for calibration. The cholesterol con-
centrations in the calibration sera were determined by the
method of Abell et al. (4).
We have used the direct method successfully for deter-
mining serum cholesterol concentrations for several Dutch
and international epidemiological and experimental studies
(6-10).
Materials and Methods
Preparation of Pools and Collection of Sera
Serum from healthy human donors, obtained from blood
banks of the Netherlands Red Cross, was filtered through a
Seitz EKS adsorption filter in a Seitz 12188 2-L stainless-steel
filter holder (Gezang & Co., 1014 BB Amsterdam, The
Netherlands) under pressure of 2-3 atm. (roughly 200-300
kPa), treated with ethylmercurithiosalicylate (0.1 g/L of fil-
trate),and stored at -20 #{176}Cuntilfurther use. Until the end
of 1976 we isolated a cholesterol-rich fraction from the serum
according to Williams et al. (11); after that time we used ul-
tracentrifugation, because inour hands itwas simplerand
yielded sera that were less turbid afterstorage. We prepared
a cholesterol-rich concentrateas follows: from a 1-L bottleof
frozenserum left atroom temperature until about 0.5 L of it
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had thawed,we discarded theremaining ice and put thefluid,
which had a cholesterol concentration of about 10 mmol/L
(3.87 g/L) into several 38-mL centrifuge tubes. After centrif-
ugation for 16 h with a Beckman Ti 60 angle rotor (Beckman
Instruments, Inc., Fullerton, CA 92364) at 18 #{176}Cand 54 000
rpm (max., 300 000 X g) a yellow-orange low-density lipo-
protein band was visible a few centimeters from the top of the
tube. We collected about 5 mL of concentrate [cholesterol
concentration about 25 mmol/L (9.67 g/L)] from each tube
and used it immediately to prepare calibrators or control
sera.
We prepared a low-cholesterol serum calibrator [concen-
tration about 2.5 mmol/L (0.97 g/L)] by mixing human serum
with horse serum (National Institute of Public Health RIV,
3721 MA Bilthoven, The Netherlands), because human serum
of such low concentration is difficult to obtain. Calibrators of
medium (about 6 mmol/L) and high (about 9 mmol/L) con-
centration were prepared by adding concentrate to human
serum. The pools were filtered asdescribed above, partitioned
into5-mL glass ampoules, and storedat -20 #{176}C.Internal
quality-control sera were prepared exactly like the medium-
and high-concentration calibrators exceptthat 2-mL am-
poules were used.Normal control pools contained about 4
mmol of cholesterol per liter (1.74 gIL) and above-normal
pools about 7.5 mmol/L (2.90 g/L). About 2.5 L of each serum
calibrator and 1 L of control serum were prepared at a time.
Throughout the period of use, sera generally were clear after
thawing.
Blood samples from subjects were collected from an an-
tecubital vein into an evacuated tube, and allowed toclot for
about 1h atroom temperature. Serum was obtained by low-
speed centrifugation, and stored at -20 #{176}C.Occasionally we
also stored samples at 4 #{176}Cfor a few days, up to a week.
Determination of Cholesterol
We used the method of Abell et al. (4), with slight modifi-
cations, to determine the cholesterol content of calibrators.
Two technicians analyzed four samples of each pool on five
separate days. Each made up his or her own solutions. Typical
CVs for the 40 samples were 1-2%, yielding standard errors
of the mean of 0.16-0.32%. Abell values for subjects’ samples
were based on replicate determinations.
For routine cholesterol determinations, we used a Presto-
matic Model 8 Automatic Chemical Analyser (Meyvis, 4614
VV Bergen op Zoom, The Netherlands), which involves vig-
orous mixing of 0.1 mL of sample (or air as a blank) with 5 mL
of an ice-cold mixture of concd. H2504 (96% purity)/glacial
acetic acid/acetic anhydride (1/3/6 by vol), stabilized with
anhydrous Na2SO4, 20 g/L.
We placed samples intoa traythatheld36 cups. Each tray
held duplicate samples of low-, medium- and high-concen-
tration calibrators, eight blanks, and single samples of pa-
tients’ or control sera. Thus, results of the direct method
represent single analyses. After incubation at 25 #{176}Cfor 25 mm
a Wang 600 microcomputer recorded the absorbance of the
calibrators, samples, or blanks in a 1-cm cuvette; we used a
Vitatron UPS 200 photometer (Meyvis), equipped with a
tungsten lamp and a 627 nm interference filter. A computer
program corrected the absorbances for carryover, calculated
a linear least-squares calibration line from the net absorbances
of the six calibrators, and converted absorbances of samples
into concentrations. Each tray thus yielded a separate cali-
bration slope.
Quality-Control Procedures
A run consistedoftheresultsofthreetoeightconsecutive
36-cup trays; sometimes two runs were completed in a day, but
one run perday was usual.Four samples eachofa normaland
an above-normal control pool were distributed throughout
each run (5). When a new batch of control serum was intro-
duced, the results of the first 20 runs were used for deter-
mining a provisional mean, standard deviation (SD), and
mean daily range; more definite values were obtained after 50
runs. Analytical systems such as the one described here tend
to show long-term “cycling effects,” in which assayed values
on control pools fluctuate above or below the mean for ex-
tended periods (5). To take this into account, we set new
control limits after each additional 20 runs by recalculating
the means and SDs for all runs performed up to that point.
This practice was abandoned in 1980, when we realizedthat
it was not in agreement with Lipid Research Clinics proce-
dures (5).
Measurements on old and new control pools generally ov-
erlapped for at least 20 runs. Results were judged by criteria
similar to those of the Lipid Research Clinics Program (5).
Specifically, all results of a run were rejected and all samples
were re-analyzed or declared lost if one or more of the fol-
lowing events occurred for either the normal or the above-
normal control:
a. A single daily mean fell outside the 3 SD limits of the
average of daily means.
b. Two successive daily means fellbetween the 2 SD and
3 SD limits.
c. Eight successive daily means fell either all above or all
below the center line.
d. A single daily range (difference between highest and
lowestof four) fellabove the 3 SD limit for the average
range.
e. Two successive range values fell between the upper 2 SD
and 3 SD limits.
f. Eight successive range values fell above the center
line.
Out-of-control data were recorded on the control charts but
not used in any calculations.
Results
Internal Quality Control
Between January 1976 and June 1981 we used three batches
of quality-control serum with a normal cholesterol concen-
tration ranging from 4.08 to 4.72 mmol/L (1.58 to 1.83 g/L),
and five above-normal pools with cholesterol ranging from
6.72 to 8.57 mmol/L (2.60 to 3.31 g/L). Analysis of control
pools by the method of Abell et al. yielded values that aver-
aged 1% higher (range: -0.3% to +3.7%) than the long-term
averages obtained with the routine method.
Because pools differed in absolute concentration, SDs and
ranges are expressed as percentages of concentration, so that
different pools can be compared.
Over the period described, the CVs of the long-term aver-
ages of the run means of these eight internal-control pools
ranged between 0.5 and 0.9%. As described above, during the
first four years we recalculated averages of run means, SDs,
and ranges every 20 runs, so as to avoid longseries of rejected
runs when the system was running for a longperiod aboveor
below the valuesetafterthe first50 runs. Quality-control
limits were not systematically affected by this procedure. The
maximum difference between a new average and the average
set after the first 50 runs ranged from 0.0 to 0.3% for the
above-normal control pools; these pools were usually ex-
hausted in about a year. For two normal-concentration pools,
which were used for two to three years each, the largest dif-
ferences between a new target average and the average set
after the first 50 runs were 0.7 and 0.9%.
The long-term average of the range, i.e., the difference be-
tween the highest and lowestvalue in one run, varied between
1.8 and 2.2% of the total concentration forthenormal pools
and between 1.6and 1.9% for theabove-normal pools, which
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this graph. For Phase IV (startingOctober 1977), each point represents 18 samples
leads to estimates of a within-run CV (12) of 0.9to 1.1%for
the normal and 0.8 to 0.9% for the above-normal pools. Sub-
traction of this within-run component of variance from the
variance of the long-term run means of control pools leaves
a between-runCV of about 0.6% for the normal pools and
about 0.5% forthe above-normal pools.
The within-run CV was also calculated for patients’ sera.
Between 1977 and 1979, 332 of the samples collected in the
Nijmegen Intervention Projectweredividedintotwo aliquots
and submitted to us under blind codes. After the codes had
been revealed we calculated a mean difference, d, between
duplicates of 0.051 mmol/L (0.02 g/L) and a mode of 0.026
mmol/L (0.01 g/L). Application of the formula SD =
i/(2d2/2n) yielded a within-run SD of 0.054 mmol/L, corre-
sponding to a CV of 1%, in excellent agreement with the values
calculated above from the ranges of the control sera.
Altogether, 453 runs were completed in the period de-
scribed; 44 of these had to be rejected. In addition, the labo-
ratory was declared “out of control” for six weeks in 1978 be-
cause of a slight but persistent decrease in the mean of an
above-normal control pool. After an overhaul of equipment
and the introduction of a new control pool a stable pattern was
again obtained.
External Quality Control
Figure 1 shows the accuracyand precisionobtained for
blind control sera provided by the Centers for Disease Control
(CDC) under the CDC/wHo Cooperative Cholesterol and
Triglyceride Standardization Program. Mont points represent
the mean of 18samples of one pool, analyzed in three months.
The upper part of Figure 1 shows the CV, a measure for pre-
cision. The lower part shows the difference between the mean
found by us and the target value assigned by CDC; this is a
measure for accuracy. Means and SDs were calculated by CDC
from the individual values submitted by us. The inaccuracy
(bias) oscillated around zero, rarely exceeding 1% for pools in
thenormal range of 5.2 to7.8 mmol/L (2.00 to3.00 g/L), or 2%
for low or high-concentration pools. The CDC/wHO criteria
for certification allow deviations of up to 5% from the target
values. As Figure 1 shows, the CVs were 1-2%, again well
within the CDC/wHo limits for imprecision: 0.07, 0.08, and
0.09 g/L for the low, medium, and high pools, respectively,
corresponding to CVs of about 2.6 to 4.7%.
Interference Due to Cholesterol Ester Fatty Acid
Composition
We wanted to test whether differences in the fatty acid
portion of cholesterol esters caused differences in apparent
cholesterol concentration according to the direct method.
Therefore we applied both the direct method and the Abell
method to sara of normolipemic subjects who had participated
in a trial of diets either low or high in linoleic acid (8). These
diets represented extremes of what can be achieved with
commonly available foodstuffs andmust have caused marked
differences in serum cholesterol ester fatty acid composition
within a few weeks (13, 14). In 15 subjects who for five weeks
ate a natural diet that provided 40% of energy as fat, 19% as
cis-cis linoleic acid, and had a polyunsaturated:saturated fat
(P:S) ratio of 1.7, the serum cholesterol concentration ac-
cording to the direct method was 1.5 ± 0.9% (mean ± SEM)
higher than the concentration determined by the Abell
method. In 14 subjects who had consumed a diet that was
identical except for its low linoleic acid content (3% of energy,
P:S ratio 0.17), this difference was 2.8 ± 1.8%. Samples from
both groups were analyzed together so as to minimize be-
tween-run effects. The differences did not differ significantly
from each other or from zero.
Similar comparisons were also made for other subjects.
Each subject was sampled once, and the serum was divided
and analyzed by both the direct method and theAbell method.
In a series of 141 sera of healthy school boys and girls (6, 7),
divided over 14 runs, the Abell values averaged 0.6% higher
(7) than values obtained with the direct method. A series of
205 sera of adultmen and women, analyzed in 10 different
runs, showed on average 1.5% higher values by the Abell than
by the direct method. The population from which these
samples were obtained had a serum cholesterol (mean ± SD)
of 5.3 ± 1.1 mmolIL (2.05 ± 0.42 g/L) for men and 5.0 ± 1.0
mmol/L (1.94 ± 0.38 g/L) for women.
Discussion
Our study shows that the inherent bias of the direct Lie-
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bermann-Burchard method (12,15) can be overcome by using
serum calibrators and strictinternaland externalquality
control. The idea of using calibrator sara to overcome this bias
is not new (16). The Lipid Research Clinics AutoAnalyzer
procedures also involve use of a serum calibrator to remove
possible bias in the assay of isopropanol extracts of serum
calibrated with isopropanol solutions of cholesterol (3).
However, we are not aware of any previous long-term evalu-
ation of the use of serum calibrators in a method where Lie-
bermann-Burchard reagent is directly added toserum.Our
results show that such a method can yield an accuracy and
precision matching those obtained in the Lipid Research
Clinics Program (17, 18), which probably represents the
“state-of-the-art” in serum lipid assays.
The direct method is suitable for epidemiological studies
of healthy subjects, but less so for clinical work, where jaun-
diced or lipemic samples may cause erroneous values (2).
Differences in the ratio of free to esterified cholesterol in
serum could also influence results, but this ratio is fairly
constant in normal subjects. However, the proportion of the
various fatty acids in the cholesterol esters can vary, and dif-
ferent cholesterol esters are reported tohave different chro-
mogenicity (3). We have tested this with sera from subjects
who had consumed for five weeks diets either very high or low
in linoleic acid (8). Such diets would cause large differences
in the proportions of the various cholesterol esters in serum.
If the chromogenicity of cholesterol linoleate is higher than
that of cholesterol oleate, then one would expect erroneously
high values for cholesterol in sera from high-linoleic acid
subjects determined by the direct method. However, no such
effect was observed, and we conclude that the difference in
chromogenicity under our conditions was negligible.
Other analyses of unselected patients’ sera by both the di-
rect method and the method of Abell et al. also showed neg-
ligible differences. It is, of course, still possible that biased
values were obtained in isolated cases, but in general the direct
method appears to give Abell-equivalent values for healthy
populations.
Although the method described in this paper is inherently
simple and rapid, the overall procedure still had a low pro-
ductivity-in part because of the time consumed in manu-
facturing and assaying pools, and, in part because of the large
proportion of the analytical capacity given over to calibration
and control samples. As a consequence, the cost per analysis
was relatively high. However, such costs formed only a minor
proportion of the total cost of the epidemiological research
projects involved, and the value added to such projects by
good standardization, in our opinion, farexceeded this ex-
pense.
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